The Key Move AbbVie Just Made To Help Its Clinch A $63 Billion DealInvestors Business Daily • 01/27/20
Fitch Ratings Says Impeachment Trial Won't Hurt Healthcare Investment in 2020The Motley Fool • 01/25/20
Retirees Should Know These 3 Facts About Required Minimum Distributions - January 17, 2020Zacks Investment Research • 01/17/20
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque PsoriasisThe Motley Fool • 01/14/20